Alpha Teknova (NASDAQ:TKNO) Stock Price Up 12.1% - Time to Buy?

Alpha Teknova, Inc. (NASDAQ:TKNO - Get Free Report)'s stock price traded up 12.1% on Monday . The stock traded as high as $5.79 and last traded at $5.75. 273,930 shares were traded during trading, a decline of 26% from the average session volume of 372,002 shares. The stock had previously closed at $5.13.

Analyst Upgrades and Downgrades

Several research analysts recently commented on TKNO shares. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Alpha Teknova in a research note on Wednesday, October 8th. Stephens upgraded shares of Alpha Teknova to a "strong-buy" rating and set a $8.00 target price on the stock in a research note on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $10.00.

Alpha Teknova Stock Up 12.1%

The company has a current ratio of 5.87, a quick ratio of 4.70 and a debt-to-equity ratio of 0.17. The firm has a market cap of $307.68 million, a PE ratio of -13.69 and a beta of 0.41. The business's 50-day simple moving average is $4.91 and its 200 day simple moving average is $5.31.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.10) by $0.03. The firm had revenue of $10.29 million for the quarter, compared to the consensus estimate of $9.90 million. Alpha Teknova had a negative net margin of 55.24% and a negative return on equity of 26.51%. Alpha Teknova has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. Balyasny Asset Management L.P. lifted its stake in shares of Alpha Teknova by 19.5% during the 2nd quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company's stock worth $4,912,000 after purchasing an additional 163,526 shares during the last quarter. CenterBook Partners LP purchased a new stake in shares of Alpha Teknova during the first quarter valued at about $1,581,000. Geode Capital Management LLC boosted its holdings in shares of Alpha Teknova by 64.4% in the 2nd quarter. Geode Capital Management LLC now owns 298,850 shares of the company's stock valued at $1,468,000 after buying an additional 117,016 shares in the last quarter. Bank of America Corp DE boosted its holdings in shares of Alpha Teknova by 3.3% in the 2nd quarter. Bank of America Corp DE now owns 229,429 shares of the company's stock valued at $1,126,000 after buying an additional 7,256 shares in the last quarter. Finally, Massar Capital Management LP grew its position in shares of Alpha Teknova by 185.7% in the 2nd quarter. Massar Capital Management LP now owns 200,000 shares of the company's stock worth $982,000 after buying an additional 130,000 shares during the last quarter. 13.81% of the stock is owned by institutional investors.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.